Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Manish Viradia (NPI 1457345324)

Field	Value
Entity Type	Individual
Organization	Manish Viradia
Address	1322 Route 31
City	Annandale
State	NJ
ZIP	08801
Taxonomy	Neurology Physician
NPI Enumerated	September 7, 2005

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: lifetime Medicare revenue of $3.7M is on file while there is no Medicaid billing on file. The absence of Medicaid activity means payer-mix analysis should treat Medicare as the dominant — and essentially sole — public payer influence on the provider's revenue profile and contracting footprint.

Revenue is highly concentrated in a very small set of infused specialty medications and procedures: the precomputed top‑3 Medicare codes account for 88.5% of the provider's Medicare revenue, driven by J1568 (55.3%), J2350 (23.4%), and J0585 (9.9%). This concentration indicates the practice’s economics are dominated by drug/infusion reimbursement rather than routine evaluation & management services.

J1568 is the single largest revenue driver: $2.1M revenue from 64.6K claims (55.3% of Medicare revenue) and a national rank of #2 of 381 providers (100th percentile; extreme outlier). That standing identifies the provider as a national outlier and high-volume site for immune globulin (octagam) infusions relative to peers.

J2350 and J0585 play distinct roles: J2350 generated $874.2K (23.4% of revenue) and ranks #30 of 105 providers nationally (72th percentile; typical, unremarkable volume for this code), while J0585 produced $369K (9.9% of revenue) and ranks #33 of 3636 providers nationally (99th percentile; notably above typical national volume). Together these show a mix of both typical market activity (J2350) and unusually high Botox administration (J0585).

High utilization of infusion/administration and supportive IV codes further supports an infusion-centered operation: 96365 (787 claims, $44.9K; ranks #158 of 8873, 98th percentile; notably above typical) and 96366 (1.1K claims, $19K; ranks #56 of 2976, 98th percentile; extreme outlier) indicate frequent initial and additional-hour IV infusions are performed in this practice. Diagnostic electrodiagnostic codes (95911, 95886, 95885) appear at modest volumes and contribute only small shares of revenue, suggesting ancillary diagnostic work complements but does not drive the business model.

Office visit E/M codes register above-average national ranks but contribute minimal revenue: 99214 ($72K, 1.9% of Medicare revenue) and 99213 ($35.3K, 0.9%) both rank in the 94th percentile, indicating steady clinical throughput despite visits being a small portion of total revenue. This pattern is consistent with a clinic where infusions and drug administrations are the primary revenue-generating services and visits support treatment delivery.

Competitive standing is mixed by code: the provider is a dominant national outlier for J1568 and among the top national performers for J0585 and select infusion administration codes, while volumes for other specialty drugs (e.g., J2350) are typical for the peer group. For payer negotiations or network strategy, these code-level rankings flag the provider as a high-capacity infusion site for certain therapies but not uniformly dominant across all neurology-related drug codes.

The provider’s NPI has been enumerated since 2005-09-07 (~21 years ago), indicating long tenure in the Medicare program. Coupled with the concentrated specialty infusion revenue mix, this longevity suggests established operational patterns (infusion infrastructure and recurring drug administration workflows) that payers and competitor analysts should consider when assessing routing, utilization management, or contracting strategies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

26 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	64,630	$30	$2.1M
J2350	Injection, ocrelizumab, 1 mg	18,600	$50	$874.2K
J0585	Injection, onabotulinumtoxina, 1 unit	73,800	$10	$369K
J3032	Injection, eptinezumab-jjmr, 1 mg	10,400	$10	$135.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	690	$100	$72K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	790	$60	$44.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	490	$70	$35.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	180	$140	$24.1K
64615	The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the…	160	$140	$22.1K
96366	The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease.	1,060	$20	$19K

Showing 1–10 of 26

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Manish Viradia — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

26 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	2	10	18,600	$50	$995.3K
J1568	1	10	5,220	$30	$445.1K
J3032	2	10	18,150	$10	$244.5K
J0585	2	110	6,100	$1	$45.6K
96413	160	230	190	$110	$26.6K
99214	1,143	13,640	130	$90	$23.6K
99213	1,367	14,090	100	$70	$13.1K
95886	81	280	60	$80	$8.6K
96365	7	320	90	$60	$8.5K
95911	29	150	30	$180	$7.8K

Showing 1–10 of 26

Related Providers

Other providers that share a Tax Identification Number (TIN) with Manish Viradia, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hunterdon Orthopedic Institute PA	NJ	Orthopaedic Surgery Physician	$0	$9.8M
Philip Glassner	NJ	Orthopaedic Surgery Physician	$338.8K	$0
Michael Pollack	NJ	Orthopaedic Surgery Physician	$314.8K	$0
Christopher Caruso	NJ	Orthopaedic Surgery Physician	$233.2K	$0
Thomas St John	NJ	Orthopaedic Surgery of the Spine Physician	$219.8K	$0
Robert More	NJ	Orthopaedic Surgery Physician	$186.6K	$0
Aleya Salam	NJ	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$185.7K	$0
Richard Chang	NJ	Orthopaedic Surgery Physician	$87.4K	$0
Patrick Wang	PA	Orthopaedic Surgery Physician	$77.9K	$0
Jerome Decker	NJ	Orthopaedic Hand Surgery Physician	$73K	$0

Nearby Providers

Other providers in the same ZIP code as Manish Viradia, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mark Malzberg	NJ	Body Imaging Physician	$711.3K	$0
Dipakkumar Pandya	NJ	Neurology Physician	$316.2K	$0

Manish Viradia — Billing Profile & Reimbursement Data

Sign up for Manish Viradia — Billing Profile & Reimbursement Data policy alerts

Manish Viradia — Billing Profile & Reimbursement Data

Sign up for Manish Viradia — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References